Study of Atomoxetine in Children With ADHD to Assess Symptomatic and Functional Outcomes

Clinical trial NCT00191633 · COMPLETED

Trial details

NCT number: NCT00191633
Sponsor: Eli Lilly and Company
Status: COMPLETED
Phase: Phase 4
Study type: INTERVENTIONAL

Attention-Deficit/Hyperactivity Disorder

Start date: 2005-04-01
Enrollment: 200

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.